Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune response
Article
[키워드] acute respiratory syndrome
Adults
adverse effect
adverse event
adverse events
Ageusia
angiotensin-converting enzyme 2
Anosmia
Bacillus
BCG
center
clinical
clinical evolution
clinical trial
convalescence
convalescent
coronavirus
coronavirus disease
COVID-19
cross-protection
double-blind
evaluated
Evolution
expected
Follow-up
humoral
humoral immune response
IgG
Immunoglobulin
immunomodulation
induce
lesions
Local
modulation
multicenter
N protein
neutralization
neutralize
NNT
offer
Other outcome
Outpatient
Patient
Placebo
placebo-controlled
placebos
prevented
Primary outcome
proportion
Randomized
receptor
recipient
Safe
Safety
SARS-CoV-2
serum
Seven
severely ill patient
significantly higher
South America
statistically significant
systemic adverse effects
treat
university
Vaccine
viral disease
virus
[DOI] 10.1111/joim.13523 PMC 바로가기
[DOI] 10.1111/joim.13523 PMC 바로가기